Ticker LaunchReverse merger · Completed · ARMP
C3J Therapeutics, Inc.
Reverse merger with AmpliPhi Biosciences Corporation
C3J Therapeutics, Inc. merged into AmpliPhi Biosciences Corporation, a NYSE American-listed bacteriophage therapeutics company, in a reverse merger that takes the private company public. The deal was announced on Jan 3, 2019 and closed on May 10, 2019. The combined company trades as Armata Pharmaceuticals, Inc. (ARMP) on NYSE American.
Armata Pharmaceuticals is a clinical-stage biotechnology company developing precisely targeted bacteriophage therapeutics, and collaborates with Merck on proprietary synthetic phage candidates.
- Status
- Completed
- Private company
- C3J Therapeutics, Inc.
- Public company
- AmpliPhi Biosciences Corporation
- Public company business before
- NYSE American-listed bacteriophage therapeutics company
- Announced
- Jan 3, 2019
- Closed
- May 10, 2019
- Combined company
- Armata Pharmaceuticals, Inc. (ARMP)
- Exchange
- NYSE American
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Form 8-K (closing) May 10, 2019
- Press release (closing)
- Press release (announcement)
- All filings on EDGAR CIK 921114
Other completed reverse mergers
- Red Cat Propware, Inc.into TimefireVR Inc. · May 15, 2019
- China VTV Ltd. (Hong Kong target)into China VTV Limited · May 8, 2019
- Adynxx, Inc.into Alliqua BioMedical, Inc. · May 3, 2019
- Charlie's Chalk Dust, LLCinto True Drinks Holdings, Inc. · Apr 26, 2019
- Oncotelic, Inc.into Mateon Therapeutics, Inc. · Apr 22, 2019
- Immunic AG (German private company)into Vital Therapies, Inc. · Apr 12, 2019